Pembrolizumab Versus Nivolumab As Second And Further Line Treatment In Non-Small Cell Lung Cancer; A Retrospective Single-Centre Study

EUROPEAN RESPIRATORY JOURNAL(2020)

引用 1|浏览22
暂无评分
关键词
Lung cancer - management, Adults, Systemic effect
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要